EAN 2021: Eptinezumab Offers Acute Benefits When Initiated During a Migraine Attack
Previous research has already demonstrated the drug’s ability to prevent migraine.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.